Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual ...
Heart failure is a major health concern and is the only manifestation of cardiovascular disease that is actually becoming more prevalent. It is responsible for more than 1 million hospitalizations per ...
The present study evaluated the diagnostic and long-term prognostic value of osteopontin levels in symptomatic patients with acute dyspnoea and peripheral oedema suspected of aCHF. Osteopontin levels ...
A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...
Intravenous corticosteroids didn't hurt people with acute heart failure (HF), and had the potential to pay off in better outcomes for some in a hypothesis-generating study based on Spain's ...
Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Heart failure happens when the heart can't pump enough blood ...
EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...
A prospective randomized phase II trial of splenic irradiation (SI) versus supportive therapy (ST) for patients (Pts) with hypersplenism (HS) secondary (2ry) to splenic periportal fibrosis (SPPF) ...
About one in 10 patients hospitalized with COVID-19 experience acute cardiac events, which are linked to nearly double the risks of ICU admission and in-hospital death, a new analysis of 2021 data ...